Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: A population-based study

Arthritis Care and Research

Volumn 65, Issue 5, 2013, Pages 816-821

  Johnsen, Svein J ^a   Brun, Johan G ^b   Gøransson, Lasse G ^a   Johannesen, Tom B ^c   Haldorsen, Karstein ^d   Harboe, Erna ^a   Jonsson, Roland ^b   Meyer, Peter A ^a   Omdal, Roald ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; RISK FACTOR; SJOEGREN SYNDROME; STANDARDIZED INCIDENCE RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NORWAY; POPULATION SURVEILLANCE; REGISTRIES; RISK FACTORS; SJOGREN'S SYNDROME; YOUNG ADULT;

EID: 84876708705     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21887     Document Type: Article

References (12)

1. Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S,. The complexity of Sjogren's syndrome: novel aspects on pathogenesis. Immunol Lett 2011; 141: 1-9.
2. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
3. Jonsson MV, Skarstein K, Jonsson R, Brun JG,. Serological implications of germinal center-like structures in primary Sjögren's syndrome. J Rheumatol 2007; 34: 2044-9.
4. Goransson L, Haldorsen K, Brun J, Harboe E, Jonsson M, Skarstein K, et al. The point prevalence of clinically relevant primary Sjogren's syndrome in two Norwegian counties. Scand J Rheumatol 2011; 40: 221-4.
5. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM, and the Members of the European Concerted Action on Sj ögren's Syndrome. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999; 42: 1765-72.
6. Zintzaras E, Voulgarelis M, Moutsopoulos HM,. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005; 165: 2337-44.
7. Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT,. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006; 65: 796-803.
8. Statistics Norway. Population changes, quarterly. URL: http://statbank.ssb.no/statistikkbanken/Default-FR.asp?PXSid=0&nvl= true&PLanguage=1&tilside=selecttable/hovedtabellHjem. asp&KortnavnWeb=folkendrkv.
9. The Cancer Registry of Norway, Institute of Population-Based Cancer Research. Cancer statistics 2008. URL: http://www.kreftregisteret.no/en/The- Registries/Cancer-Statistics/.
10. Birlik M, Akar S, Gurler O, Sari I, Birlik B, Sarioglu S, et al. Prevalence of primary Sjogren's syndrome in Turkey: a population-based epidemiological study. Int J Clin Pract 2009; 63: 954-61.
11. Kauppi M, Pukkala E, Isomaki H,. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 1997; 8: 201-4.
12. Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006; 98: 51-60.